|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1-adrenergic receptor, CaM Kinase II dependent pathway mediates cardiac myocyte fetal gene induction
1 Cardiology, University of Colorado Cardiovascular Institute, Denver, CO, USA
* To whom correspondence should be addressed. E-mail: michael.bristow{at}uchsc.edu.
-adrenergic signaling plays an important role in the natural history of dilated cardiomyopathies. Chronic activation of
-adrenergic receptors (
1-AR and
2-AR) during periods of cardiac stress ultimately harms the failing heart by mechanisms that include alterations in gene expression. Here, we show that stimulation of
-ARs with isoproterenol in neonate rat ventricular myocytes causes a "fetal" response in the relative activities of the human cardiac fetal/adult gene promoters that includes repression of the human and rat
-MyHC promoters with simultaneous activation of the human ANP and rat
MyHC promoters. We also show that the promoter changes correlate with changes in endogenous gene expression as measured by mRNA expression. Furthermore, we show that these changes are specifically mediated by the
1-AR but not the
2-AR, and are independent of
1-adrenergic receptor stimulation. We also demonstrate that the fetal gene response is independent of cAMP and PKA while inhibition of Ca2+/calmodulin dependent protein kinase (CaMK) pathway blocks isoproterenol mediated fetal gene program induction. Finally, we show that induction of the fetal program is dependent on activation of L-Type Ca2+ channel (LTCC). We conclude that in neonatal rat cardiac myocytes, agonist occupied
1-AR mobilizes Ca2+ stores to activate fetal gene induction through cAMP independent pathways that involve CaMK.
This article has been cited by other articles:
![]() |
Z. Lin, I. Murtaza, K. Wang, J. Jiao, J. Gao, and P.-F. Li miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy PNAS, July 21, 2009; 106(29): 12103 - 12108. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pandya, K. Porter, H. A. Rockman, and O. Smithies Decreased beta-adrenergic responsiveness following hypertrophy occurs only in cardiomyocytes that also re-express beta-myosin heavy chain Eur J Heart Fail, July 1, 2009; 11(7): 648 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Metrich, A. Lucas, M. Gastineau, J.-L. Samuel, C. Heymes, E. Morel, and F. Lezoualc'h Epac Mediates {beta}-Adrenergic Receptor-Induced Cardiomyocyte Hypertrophy Circ. Res., April 25, 2008; 102(8): 959 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Muthumala, F. Drenos, P. M. Elliott, and S. E. Humphries Role of {beta} adrenergic receptor polymorphisms in heart failure: Systematic review and meta-analysis Eur J Heart Fail, January 1, 2008; 10(1): 3 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Mao, S. Fukuoka, C. Iwai, J. Liu, V. K. Sharma, S.-S. Sheu, M. Fu, and C.-s. Liang Cardiomyocyte apoptosis in autoimmune cardiomyopathy: mediated via endoplasmic reticulum stress and exaggerated by norepinephrine Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1636 - H1645. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kang, K. Y. Chung, and J. W. Walker G-Protein Coupled Receptor Signaling in Myocardium: Not for the Faint of Heart Physiology, June 1, 2007; 22(3): 174 - 184. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |